|
1
|
Gorelick PB and Pantoni L: Advances in
vascular cognitive impairment. Stroke. 44:307–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chui HC: Vascular cognitive impairment:
today and tomorrow. Alzheimers Dement. 2:185–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moorhouse P and Rockwood K: Vascular
cognitive impairment: current concepts and clinical developments.
Lancet Neurol. 7:246–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Consoli A, Pasi M and Pantoni L: Vascular
mild cognitive impairment: concept, definition, and directions for
future studies. Aging Clin Exp Res. 24:113–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dichgans M and Zietemann V: Prevention of
vascular cognitive impairment. Stroke. 43:3137–3146. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalaria RN: Cerebrovascular disease and
mechanisms of cognitive impairment: evidence from
clinicopathological studies in humans. Stroke. 43:2526–2534. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luckhaus C, Flüb MO, Wittsack HJ, et al:
Detection of changed regional cerebral blood flow in mild cognitive
impairment and early Alzheimer’s dementia by perfusion-weighted
magnetic resonance imaging. Neuroimage. 40:495–503. 2008.PubMed/NCBI
|
|
8
|
Panza F, Frisardi V, Capurso C, et al:
Metabolic syndrome and cognitive impairment: current epidemiology
and possible underlying mechanisms. J Alzheimers Dis. 21:691–724.
2010.PubMed/NCBI
|
|
9
|
Clare R, King VG, Wirenfeldt M and Vinters
HV: Synapse loss in dementias. J Neurosci Res. 88:2083–2090. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jesky R and Hailong C: Are herbal
compounds the next frontier for alleviating learning and memory
impairments? An integrative look at memory, dementia and the
promising therapeutics of traditional chinese medicines. Phytother
Res. 25:1105–1118. 2011. View
Article : Google Scholar
|
|
11
|
Liu X, Du J, Cai J, Xu G, Lin A and Teng
Q: Clinical systematic observation of Kangxin capsule curing
vascular dementia of senile kidney deficiency and blood stagnation
type. J Ethnopharmacol. 112:350–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moss G: The adequacy of the cerebral
collateral circulation: tolerance of awake experimental animals to
acute bilateral common carotid artery occlusion. J Surg Res.
16:337–338. 1974. View Article : Google Scholar
|
|
13
|
Brondino N, De Silvestri A, Re S, et al: A
Systematic review and meta-analysis of ginkgo biloba in
neuropsychiatric disorders: from ancient tradition to modern-day
medicine. Evid Based Complement Alternat Med. 2013:9156912013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ihl R: Effects of Ginkgo biloba extract
EGb 761 in dementia with neuropsychiatric features: review of
recently completed randomised, controlled trials. Int J Psychiatry
Clin Pract. 1(Suppl 1): 8–14. 2013. View Article : Google Scholar
|
|
15
|
Morris R: Developments of a water-maze
procedure for studying spatial learning in the rat. J Neurosci
Methods. 11:47–60. 1984. View Article : Google Scholar
|
|
16
|
Feng Z, Lu Y, Wu X, et al: Ligustilide
alleviates brain damage and improves cognitive function in rats of
chronic cerebral hypoperfusion. J Ethnopharmacol. 144:313–321.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scheff SW, Price DA, Schmitt FA, et al:
Synaptic alterations in CA1 in mild Alzheimer disease and mild
cognitive impairment. Neurology. 68:1501–1508. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Xing A, Xu C, Cai Q, Liu H and Li
L: Cerebrovascular hypoperfusion induces spatial memory impairment,
synaptic changes, and amyloid-β oligomerization in rats. J
Alzheimers Dis. 21:813–822. 2010.PubMed/NCBI
|
|
19
|
O’Brien JT, Erkinjuntti T, Reisberg B, et
al: Vascular cognitive impairment. Lancet Neurol. 2:89–98.
2003.
|
|
20
|
Ramos-Estébanez C, Moral-Arce I,
Muñoz-Arrondo R, et al: Vascular cognitive impairment: prodromal
stages of ischemic vascular dementia. Dement Geriatr Cogn Disord.
25:451–460. 2008.PubMed/NCBI
|
|
21
|
Hachinski V, Iadecola C, Petersen RC, et
al: National Institute of Neurological Disorders and
Stroke-Canadian Stroke Network vascular cognitive impairment
harmonization standards. Stroke. 37:2220–2241. 2006. View Article : Google Scholar
|
|
22
|
Bowler JV: Modern concept of vascular
cognitive impairment. Br Med Bull. 83:291–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D’Hooge R and De Deyn PP: Applications of
the Morris water maze in the study of learning and memory. Brain
Res Brain Res Rev. 36:60–90. 2001.PubMed/NCBI
|
|
24
|
Dong H, Martin MV, Chambers S and
Csernansky JG: Spatial relationship between synapse loss and
beta-amyloid deposition in Tg2576 mice. J Comp Neurol. 500:311–321.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marcello E, Epis R, Saraceno C and Di Luca
M: Synaptic dysfunction in Alzheimer’s disease. Adv Exp Med Biol.
970:573–601. 2012.
|
|
26
|
Yao ZB, Li X and Xu ZC: GABAergic and
asymmetrical synapses on somata of GABAergic neurons in CA1 and CA3
regions of rat hippocampus. A quantitative electron microscopic
analysis. Stroke. 27:1411–1415. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hai J, Yu F, Lin Q and Su SH: The changes
of signal transduction pathways in hippocampal regions and
postsynaptic densities after chronic cerebral hypoperfusion in
rats. Brain Res. 1429:9–17. 2012. View Article : Google Scholar
|
|
28
|
Berr C, Balansard B, Arnaud J, Roussel AM
and Alperovitch A: Cognitive decline is associated with systemic
oxidative stress: the EVA study. Etude du Vieillissement Artériel.
J Am Geriatr Soc. 48:1285–1291. 2000.PubMed/NCBI
|
|
29
|
Reiter RJ: Oxidative processes and
antioxidative defense mechanisms in the aging brain. FASEB J.
9:526–533. 1995.PubMed/NCBI
|
|
30
|
Mecocci P, Mariani E, Cornacchiola V and
Polidori MC: Antioxidants for the treatment of mild cognitive
impairment. Neurol Res. 26:598–602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bennett S, Grant MM and Aldred S:
Oxidative stress in vascular dementia and Alzheimer’s disease: a
common pathology. J Alzheimers Dis. 17:245–257. 2009.
|
|
32
|
López N, Tormo C, De Blas I, Llinares I
and Alom J: Oxidative stress in Alzheimer’s disease and mild
cognitive impairment with high sensitivity and specificity. J
Alzheimers Dis. 33:823–829. 2013.
|
|
33
|
Yuan D, Wang H, He H, et al: Protective
effects of total flavonoids from Epimedium on the male mouse
reproductive system against cyclophosphamide-induced oxidative
injury by up-regulating the expressions of SOD3 and GPX1. Phytother
Res. 28:88–97. 2014. View
Article : Google Scholar
|
|
34
|
Cheng H, Feng S, Jia X, Li Q, Zhou Y and
Ding C: Structural characterization and antioxidant activities of
polysaccharides extracted from Epimedium acuminatum. Carbohydr
Polym. 92:63–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu YC and Hsieh CL: Pharmacological
effects of Radix Angelica Sinensis (Danggui) on cerebral
infarction. Chin Med. 6:322011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mansour SM, Bahgat AK, El-Khatib AS and
Khayyal MT: Ginkgo biloba extract (EGb 761) normalizes hypertension
in 2K, 1C hypertensive rats: role of antioxidant mechanisms, ACE
inhibiting activity and improvement of endothelial dysfunction.
Phytomedicine. 18:641–647. 2011. View Article : Google Scholar
|
